<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8" />
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=1.0, maximum-scale=1.0, minimum-scale=1.0, user-scalable=no" />
        <title>References</title>

        <link href="../jquery-mobile/jquery.mobile.theme-1.2.0.min.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.swatch.f.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.swatch.l.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/custom_arrow.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.structure-1.2.0.min.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/full.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/recreated_tables.css" rel="stylesheet" type="text/css"/>
        <script src="../jquery-mobile/jquery-1.8.2.min.js" type="text/javascript"></script>
        <script src="../jquery-customization.js" type="text/javascript"></script>
        <script src="../jquery-mobile/jquery.mobile-1.2.0.min.js" type="text/javascript"></script>
        <script src="../cordova-2.2.0.js" type="text/javascript" charset="utf-8"></script>
        <script src="../assets/js/metrics.js" type="text/javascript" charset="utf-8"></script>

    </head>
    <body>

        <!-- Start of page -->
        <div data-role="page" id="heading_page_9" data-theme="d">
            <div data-role="header" data-id="references-header" data-theme="l" data-position="fixed">
                <a href="lv-0.html" data-role="button" data-iconshadow="false" data-corners="false" data-theme="reset" data-transition="fade" class="back_button" role="button" aria-label="back"></a>
                <h1>References</h1>
	            <a href="../menu.html"  rel="external" data-role="button" data-theme="reset" data-transition="fade" data-iconshadow="false" data-corners="false" class="menu_button ui-btn-right" role="button" aria-label="main menu"></a>
            </div>  <!-- end of header div -->

            <div data-role="content">
            <div id=references_breadcrumbs>
            
                    <a href="lv-0.html" >References</a><span class="carrot"> > </span>References 401-450
            </div>   <!-- end of references listview breadcrumbs -->
            </br><h1 id="sigil_toc_id_8">
 References 401-450
</h1>
<p>
 401. Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet 2000;356(9234):1013&ndash;19.
</p>
<p>
 402. Tracy CR, Steers WD, Costabile R. Diagnosis and management of epididymitis. Urol Clin North Am 2008;35:101&ndash;8.
</p>
<p>
 403. Nickel JC, Siemens DR, Nickel KR, et al. The patient with chronic epididymitis: characterization of an enigmatic syndrome. J Urol 2002;167:1701&ndash;4.
</p>
<p>
 404. Cogliano V, Baan R, Straif K, et al. Carcinogenicity of human papillomaviruses.&nbsp;Lancet Oncol 2005;6:204.
</p>
<p>
 405. Myers ER, McCrory DC, Nanda K, et al. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000;151:1158&ndash;71.
</p>
<p>
 406. Garland SM, Steben M, Sings HL, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009;199:805&ndash;14.
</p>
<p>
 407. Gotovtseva EP, Kapadia AS, Smolensky MH, et al. Optimal frequency of imiquimod (aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: a meta-analysis. Sex Transm Dis 2008;35:346&ndash;51.
</p>
<p>
 408. Mashiah J, Brenner S. Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod. Clin Exp Dermatol 2008;33:74&ndash;6.
</p>
<p>
 409. Tatti S, Swinehart JM, Thielert C, et al. Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial. Obstet Gynecol 2008;111:1371&ndash;9.
</p>
<p>
 410. Stockfleth E, Beti H, Orasan R, et al. Topical Polyphenon E in the treatment&nbsp;of external genital and perianal warts: a randomized controlled trial. Br J Dermatol 2008;158:1329&ndash;38.
</p>
<p>
 411. Gross G, Meyer KG, Pres H, et al. A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts. J Eur Acad Dermatol Venereol 2007;21:1404&ndash;12.
</p>
<p>
 412. Silverberg MJ, Thorsen P, Lindeberg H, et al. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis.&nbsp;Obstet Gynecol 2003;101:645&ndash;52.
</p>
<p>
 413. Dolev JC, Maurer T, Springer G, et al. Incidence and risk factors for verrucae in women. AIDS 2008;22:1213&ndash;19.
</p>
<p>
 414. Silverberg MJ, Ahdieh L, Munoz A, et al. The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex Transm Dis 2002;29:427&ndash;35.
</p>
<p>
 415. De Panfilis G., Melzani G, Mori G, et al. Relapses after treatment of external genital warts are more frequent in HIV-positive patients than in HIV-negative controls. Sex Transm Dis 2002;29:121&ndash;5.
</p>
<p>
 416. Conley LJ, Ellerbrock TV, Bush TJ, et al. HIV-1 infection and risk of vulvovaginal&nbsp;and perianal condylomata acuminata and intraepithelial neoplasia:&nbsp;a prospective cohort study. Lancet 2002;359(9301):108&ndash;13.
</p>
<p>
 417. Chiao EY, Giordano TP, Palefsky JM, et al. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis 2006;43:223&ndash;33.
</p>
<p>
 418. Datta SD, Koutsky LA, Ratelle S, et al. Human papillomavirus infection&nbsp;and cervical cytology in women screened for cervical cancer in the United States, 2003&ndash;2005. Ann Intern Med 2008;148:493&ndash;500.
</p>
<p>
 419. Selvam N, Barrow R, Shlay J, et al. Should STD clinics participate in cervical cancer screening: (1) Measurement of pap test abnormalities and HPV infection among women attending STD clinics and (2) A survey of cervical cancer screening practices, ISSTDR, Seattle, WA 2007.
</p>
<p>
 420. Arbyn M, Bergeron C, Klinkhamer P, et al. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol 2008;111:167&ndash;77.
</p>
<p>
 421. Stoler MH, Castle PE, Solomon D, et al. The expanded use of HPV testing&nbsp;in gynecologic practice per ASCCP-guided management requires the use of well-validated assays. Am J Clin Pathol 2007;127:335&ndash;7.
</p>
<p>
 422. Solomon D, Davey D, Kurman R, et al; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114&ndash;9.
</p>
<p>
 423. Naucler P, Ryd W, Tornberg S, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007;357:1589&ndash;97.
</p>
<p>
 424. Wright TC, Jr., Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007;11:201&ndash;22.
</p>
<p>
 425. Widdice LE, Moscicki AB. Updated guidelines for Papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents. J Adolesc Health 2008;43(4 Suppl):S41&ndash;S51.
</p>
<p>
 426. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293&ndash;9.
</p>
<p>
 427. American Society for Colposcopy and Cervical Pathology (ASCCP). HPV Genotyping Clinical Update. Available at: http://www.asccp.org/pdfs/consensus/clinical_update_20090408.pdf.
</p>
<p>
 428. American Society for Colposcopy and Cervical Pathology (ASCCP) Clinical Update for HPV Genotyping, 2009.
</p>
<p>
 429. Wright TC, Jr., Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis 2007;11:223&ndash;39.
</p>
<p>
 430. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing&nbsp;alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst 2008;100:492&ndash;501.
</p>
<p>
 431. Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus&nbsp;DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007;357:1579&ndash;88.
</p>
<p>
 432. Ghanem KG, Koumans EH, Johnson RE, et al. Effect of specimen order on Chlamydia trachomatis and Neisseria gonorrhoeae test performance&nbsp;and adequacy of Papanicolaou smear. J Pediatr Adolesc Gynecol 2006;19:23&ndash;30.
</p>
<p>
 433. Saraiya M, Lee NC, Blackman D, et al. Self-reported Papanicolaou smears and hysterectomies among women in the United States. Obstet Gynecol 2001;98:269&ndash;78.
</p>
<p>
 434. Sirovich BE, Welch HG. Cervical cancer screening among women without a cervix. JAMA 2004;291:2990&ndash;3.
</p>
<p>
 435. Stokes-Lampard H, Wilson S, Waddell C, et al. Vaginal vault smears after hysterectomy for reasons other than malignancy: a systematic review of the literature. BJOG 2006;113:1354&ndash;65.
</p>
<p>
 436. Delmas MC, Larsen C, van BB, et al. Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression.&nbsp;European Study Group on Natural History of HIV Infection in Women. AIDS 2000;14:1775&ndash;84.
</p>
<p>
 437. CDC. Surveillance for acute viral hepatitis. MMWR 2008;57(No.SS-2):1-24.
</p>
<p>
 438. CDC. Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2007;56:1080&ndash;4.
</p>
<p>
 439. Alter HJ, Purcell RH, Gerin JL, et al. Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen. Infect Immun 1977;16:928&ndash;33.
</p>
<p>
 440. Villarejos VM, Visona KA, Gutierrez A, et al. Role of saliva, urine and feces in the transmission of type B hepatitis. N Engl J Med 1974;291:1375&ndash;1378.
</p>
<p>
 441. Davis LG, Weber DJ, Lemon SM. Horizontal transmission of hepatitis B virus. Lancet 1989;1(8643):889&ndash;93.
</p>
<p>
 442. Martinson FE, Weigle KA, Royce RA, et al. Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. Am J Epidemiol 1998;147:478&ndash;87.
</p>
<p>
 443. CDC. National, state, and urban area vaccination coverage among children aged 19&ndash;35 months&mdash;United States, 2004. MMWR 2005;54:717&ndash;21.
</p>
<p>
 444. CDC. Hepatitis B vaccination among high-risk adolescents and adults&ndash;San Diego, California, 1998&ndash;2001. MMWR 2002;51:618&ndash;21.
</p>
<p>
 445. MacKellar DA, Valleroy LA, Secura GM, et al. Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. Am J Public Health 2001;91:965&ndash;71.
</p>
<p>
 446. CDC. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR 2001;50(No. RR-11).
</p>
<p>
 447. Bohlke K, Davis RL, Marcy SM, et al. Risk of anaphylaxis after vaccination&nbsp;of children and adolescents. Pediatrics 2003;112:815&ndash;20.
</p>
<p>
 448. Minuk GY, Bohme CE, Bowen TJ, et al. Efficacy of commercial condoms&nbsp;in the prevention of hepatitis B virus infection. Gastroenterology 1987;93:710&ndash;4.
</p>
<p>
 449. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705&ndash;14.
</p>
<p>
 450. Brettler DB, Mannucci PM, Gringeri A, et al. The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study. Blood 1992;80:540&ndash;3.
</p>

            </div>
            <script type="text/javascript">

                $('div').live('pageshow', function (event, ui) {
                    document.addEventListener("deviceready", function(){
                        trackReferencesPageView("9");
                                                },true);
                });
            </script>
        </div>
        <!-- end of references heading page -->
    </body>
</html>

    